ID   HMHA1_HUMAN             Reviewed;        1136 AA.
AC   Q92619; B4DTS4; F6QP70; Q6P189; Q7LE26; Q86WS1; Q8HX84; Q9GJN9; Q9GJP0;
AC   Q9GJP1; Q9MY24;
DT   29-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   29-APR-2008, sequence version 2.
DT   28-JUN-2023, entry version 173.
DE   RecName: Full=Rho GTPase-activating protein 45 {ECO:0000312|HGNC:HGNC:17102};
DE   Contains:
DE     RecName: Full=Minor histocompatibility antigen HA-1;
DE              Short=mHag HA-1;
GN   Name=ARHGAP45 {ECO:0000312|HGNC:HGNC:17102};
GN   Synonyms=HMHA1 {ECO:0000312|HGNC:HGNC:17102}, KIAA0223
GN   {ECO:0000312|HGNC:HGNC:17102};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11095984; DOI=10.1006/bbrc.2000.3880;
RA   Kaminski W.E., Piehler A., Schmitz G.;
RT   "Genomic organization of the human cholesterol-responsive ABC transporter
RT   ABCA7: tandem linkage with the minor histocompatibility antigen HA-1
RT   gene.";
RL   Biochem. Biophys. Res. Commun. 278:782-789(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=9039502; DOI=10.1093/dnares/3.5.321;
RA   Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O.,
RA   Tanaka A., Kotani H., Miyajima N., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. VI. The
RT   coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of
RT   cDNA clones from cell line KG-1 and brain.";
RL   DNA Res. 3:321-329(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS HIS-139;
RP   ASP-259 AND GLY-439.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 82-140, AND VARIANT HIS-139.
RX   PubMed=10958358; DOI=10.1034/j.1399-0039.2000.560109.x;
RA   Arostegui J.I., Gallardo D., Rodriguez-Luaces M., Querol S., Madrigal J.A.,
RA   Garcia-Lopez J., Granena A.;
RT   "Genomic typing of minor histocompatibility antigen HA-1 by reference
RT   strand mediated conformation analysis (RSCA).";
RL   Tissue Antigens 56:69-76(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 82-140, AND VARIANT HIS-139.
RX   PubMed=16202172; DOI=10.1186/1471-2350-6-36;
RA   Graziano C., Giorgi M., Malentacchi C., Mattiuz P.L., Porfirio B.;
RT   "Sequence diversity within the HA-1 gene as detected by melting temperature
RT   assay without oligonucleotide probes.";
RL   BMC Med. Genet. 6:36-36(2005).
RN   [9]
RP   PROTEIN SEQUENCE OF 137-145, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   VARIANT HIS-139.
RX   PubMed=9461441; DOI=10.1126/science.279.5353.1054;
RA   den Haan J.M., Meadows L.M., Wang W., Pool J., Blokland E., Bishop T.L.,
RA   Reinhardus C., Shabanowitz J., Offringa R., Hunt D.F., Engelhard V.H.,
RA   Goulmy E.;
RT   "The minor histocompatibility antigen HA-1: a diallelic gene with a single
RT   amino acid polymorphism.";
RL   Science 279:1054-1057(1998).
RN   [10]
RP   FUNCTION.
RX   PubMed=8260714;
RA   Marijt W.A.F., Veenhof W.F.J., Goulmy E., Willemze R., van Rood J.J.,
RA   Falkenburg J.H.F.;
RT   "Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific
RT   cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth
RT   by a mechanism that is dependent on direct cell-cell contact.";
RL   Blood 82:3778-3785(1993).
RN   [11]
RP   FUNCTION.
RX   PubMed=8532022; DOI=10.1056/nejm199602013340501;
RA   Goulmy E., Schipper R., Pool J., Blokland E., Falkenburg J.H., Vossen J.,
RA   Gratwohl A., Vogelsang G.B., van Houwelingen H.C., van Rood J.J.;
RT   "Mismatches of minor histocompatibility antigens between HLA-identical
RT   donors and recipients and the development of graft-versus-host disease
RT   after bone marrow transplantation.";
RL   N. Engl. J. Med. 334:281-285(1996).
RN   [12]
RP   TISSUE SPECIFICITY.
RX   PubMed=8843592; DOI=10.1016/s0966-3274(96)80009-8;
RA   van Lochem E., van der Keur M., Mommaas A.M., de Gast G.C., Goulmy E.;
RT   "Functional expression of minor histocompatibility antigens on human
RT   peripheral blood dendritic cells and epidermal Langerhans cells.";
RL   Transpl. Immunol. 4:151-157(1996).
RN   [13]
RP   FUNCTION.
RX   PubMed=9798702; DOI=10.1097/00007890-199810150-00016;
RA   Rufer N., Wolpert E., Helg C., Tiercy J.-M., Gratwohl A., Chapuis B.,
RA   Jeannet M., Goulmy E., Roosnek E.;
RT   "HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor
RT   histocompatibility antigens after bone marrow transplantation.";
RL   Transplantation 66:910-916(1998).
RN   [14]
RP   TISSUE SPECIFICITY.
RX   PubMed=11965046; DOI=10.1097/00007890-200204150-00022;
RA   Fujii N., Hiraki A., Ikeda K., Ohmura Y., Nozaki I., Shinagawa K.,
RA   Ishimaru F., Kiura K., Shimizu N., Tanimoto M., Harada M.;
RT   "Expression of minor histocompatibility antigen, HA-1, in solid tumor
RT   cells.";
RL   Transplantation 73:1137-1141(2002).
RN   [15]
RP   FUNCTION.
RX   PubMed=12601144; DOI=10.1073/pnas.0530192100;
RA   Marijt W.A.E., Heemskerk M.H.M., Kloosterboer F.M., Goulmy E.,
RA   Kester M.G.D., van der Hoorn M.A.W.G., van Luxemburg-Heys S.A.P.,
RA   Hoogeboom M., Mutis T., Drijfhout J.W., van Rood J.J., Willemze R.,
RA   Falkenburg J.H.F.;
RT   "Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-
RT   specific T cells can induce complete remissions of relapsed leukemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:2742-2747(2003).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23 AND SER-25, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99 AND SER-569, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using sequential
RT   IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-73; SER-93; SER-99;
RP   SER-569 AND SER-619, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-73; SER-569 AND
RP   SER-592, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   FUNCTION, DOMAIN, AND SUBCELLULAR LOCATION.
RX   PubMed=24086303; DOI=10.1371/journal.pone.0073962;
RA   de Kreuk B.J., Schaefer A., Anthony E.C., Tol S., Fernandez-Borja M.,
RA   Geerts D., Pool J., Hambach L., Goulmy E., Hordijk P.L.;
RT   "The human minor histocompatibility antigen 1 is a RhoGAP.";
RL   PLoS ONE 8:E73962-E73962(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-569; SER-578; SER-619
RP   AND SER-949, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   VARIANT HIS-139.
RX   PubMed=9820595; DOI=10.1111/j.1399-0039.1998.tb03052.x;
RA   Tseng L.-H., Lin M.-T., Martin P.J., Pei J., Smith A.G., Hansen J.A.;
RT   "Definition of the gene encoding the minor histocompatibility antigen HA-1
RT   and typing for HA-1 from genomic DNA.";
RL   Tissue Antigens 52:305-311(1998).
RN   [25]
RP   VARIANT HIS-139.
RX   PubMed=16399573; DOI=10.1016/j.bbmt.2005.09.017;
RA   Di Terlizzi S., Zino E., Mazzi B., Magnani C., Tresoldi C., Perna S.K.,
RA   Bregni M., Rossini S., Ciceri F., Bordignon C., Bonini C., Fleischhauer K.;
RT   "Therapeutic and diagnostic applications of minor histocompatibility
RT   antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell
RT   transplantation: a survey of different populations.";
RL   Biol. Blood Marrow Transplant. 12:95-101(2006).
CC   -!- FUNCTION: Contains a GTPase activator for the Rho-type GTPases (RhoGAP)
CC       domain that would be able to negatively regulate the actin cytoskeleton
CC       as well as cell spreading. However, also contains N-terminally a BAR-
CC       domin which is able to play an autoinhibitory effect on this RhoGAP
CC       activity. {ECO:0000269|PubMed:24086303}.
CC   -!- FUNCTION: Precursor of the histocompatibility antigen HA-1. More
CC       generally, minor histocompatibility antigens (mHags) refer to
CC       immunogenic peptide which, when complexed with MHC, can generate an
CC       immune response after recognition by specific T-cells. The peptides are
CC       derived from polymorphic intracellular proteins, which are cleaved by
CC       normal pathways of antigen processing. The binding of these peptides to
CC       MHC class I or class II molecules and its expression on the cell
CC       surface can stimulate T-cell responses and thereby trigger graft
CC       rejection or graft-versus-host disease (GVHD) after hematopoietic stem
CC       cell transplantation from HLA-identical sibling donor. GVHD is a
CC       frequent complication after bone marrow transplantation (BMT), due to
CC       mismatch of minor histocompatibility antigen in HLA-matched sibling
CC       marrow transplants. Specifically, mismatching for mHag HA-1 which is
CC       recognized as immunodominant, is shown to be associated with the
CC       development of severe GVHD after HLA-identical BMT. HA-1 is presented
CC       to the cell surface by MHC class I HLA-A*0201, but also by other HLA-A
CC       alleles. This complex specifically elicits donor-cytotoxic T-lymphocyte
CC       (CTL) reactivity against hematologic malignancies after treatment by
CC       HLA-identical allogenic BMT. It induces cell recognition and lysis by
CC       CTL. {ECO:0000269|PubMed:12601144, ECO:0000269|PubMed:8260714,
CC       ECO:0000269|PubMed:8532022, ECO:0000269|PubMed:9798702}.
CC   -!- SUBUNIT: HA-1 forms a complex with MHC class I HLA-A*0201.
CC   -!- INTERACTION:
CC       Q92619; Q8TD16-2: BICD2; NbExp=3; IntAct=EBI-2825900, EBI-11975051;
CC       Q92619; Q9P107: GMIP; NbExp=3; IntAct=EBI-2825900, EBI-11603420;
CC       Q92619; Q08379: GOLGA2; NbExp=3; IntAct=EBI-2825900, EBI-618309;
CC       Q92619; O75031: HSF2BP; NbExp=3; IntAct=EBI-2825900, EBI-7116203;
CC       Q92619; Q5VU43-2: PDE4DIP; NbExp=3; IntAct=EBI-2825900, EBI-9640281;
CC       Q92619; Q4G0R1: PIBF1; NbExp=3; IntAct=EBI-2825900, EBI-14066006;
CC       Q92619; Q96KQ4: PPP1R13B; NbExp=3; IntAct=EBI-2825900, EBI-1105153;
CC       Q92619; P63000: RAC1; NbExp=3; IntAct=EBI-2825900, EBI-413628;
CC       Q92619; Q6NUQ1: RINT1; NbExp=5; IntAct=EBI-2825900, EBI-726876;
CC       Q92619; Q05BL1: TP53BP2; NbExp=3; IntAct=EBI-2825900, EBI-11952721;
CC       Q92619; Q86XT4: TRIM50; NbExp=3; IntAct=EBI-2825900, EBI-9867283;
CC       Q92619; Q96AP4: ZUP1; NbExp=3; IntAct=EBI-2825900, EBI-744706;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:24086303}. Cell
CC       projection, ruffle membrane {ECO:0000269|PubMed:24086303}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q92619-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92619-2; Sequence=VSP_044707;
CC   -!- TISSUE SPECIFICITY: Expressed on cells of the hematopoietic lineage.
CC       Detected in dendritic cells and epidermal Langerhans cells. Expressed
CC       in peripheral blood mononuclear cells, in all leukemia/lymphoma cell
CC       lines. Detected also in some solid tumors and tissues such as cancerous
CC       and non-cancerous tissue. {ECO:0000269|PubMed:11965046,
CC       ECO:0000269|PubMed:8843592}.
CC   -!- DOMAIN: Rho-GAP domain is able to regulate RhoGTPase activity, actin
CC       cytoskeleton and cell spreading. However N-terminally BAR domain plays
CC       an autoinhibitory role. {ECO:0000269|PubMed:24086303}.
CC   -!- POLYMORPHISM: The HA-1H allele is presented on the cell surface and
CC       recognized by CTL, whereas the HA-1R allele is poorly represented by
CC       HLA-A and non-immunogenic, although HA-1R allelic frequency is the
CC       highest (PubMed:9820595, PubMed:16399573).
CC       {ECO:0000269|PubMed:16399573, ECO:0000269|PubMed:9820595}.
CC   -!- MISCELLANEOUS: Infusion of lymphocyte from mHag HA-1-negative donors
CC       results in a durable remission in mHag HA-1-positive patients with
CC       leukemia or multiple myeloma.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA13212.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF308066; AAN04658.1; -; Genomic_DNA.
DR   EMBL; AF308045; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308046; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308047; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308048; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308049; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308050; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308051; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308052; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308053; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308054; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308055; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308056; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308057; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308058; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308059; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308060; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308061; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308062; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308063; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308064; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF308065; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; AF311102; AAN04658.1; JOINED; Genomic_DNA.
DR   EMBL; D86976; BAA13212.1; ALT_INIT; mRNA.
DR   EMBL; AK300341; BAG62086.1; -; mRNA.
DR   EMBL; AC004151; AAC03237.1; -; Genomic_DNA.
DR   EMBL; AC011558; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093066; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471139; EAW69551.1; -; Genomic_DNA.
DR   EMBL; BC048129; AAH48129.1; -; mRNA.
DR   EMBL; BC065223; AAH65223.1; -; mRNA.
DR   EMBL; AF207595; AAG02014.1; -; Genomic_DNA.
DR   EMBL; AF207596; AAG02015.1; -; Genomic_DNA.
DR   EMBL; AF207597; AAG02016.1; -; Genomic_DNA.
DR   EMBL; AF236756; AAF91292.1; -; Genomic_DNA.
DR   CCDS; CCDS32863.1; -. [Q92619-1]
DR   CCDS; CCDS58637.1; -. [Q92619-2]
DR   PIR; D59433; D59433.
DR   RefSeq; NP_001245257.1; NM_001258328.2. [Q92619-2]
DR   RefSeq; NP_001269263.1; NM_001282334.1.
DR   RefSeq; NP_001269264.1; NM_001282335.1.
DR   RefSeq; NP_036424.2; NM_012292.4. [Q92619-1]
DR   PDB; 3D25; X-ray; 1.30 A; C=140-145.
DR   PDB; 3FT3; X-ray; 1.95 A; P=137-145.
DR   PDBsum; 3D25; -.
DR   PDBsum; 3FT3; -.
DR   AlphaFoldDB; Q92619; -.
DR   SMR; Q92619; -.
DR   BioGRID; 117072; 21.
DR   IntAct; Q92619; 20.
DR   STRING; 9606.ENSP00000439601; -.
DR   GlyCosmos; Q92619; 2 sites, 2 glycans.
DR   GlyGen; Q92619; 2 sites, 2 O-linked glycans (2 sites).
DR   iPTMnet; Q92619; -.
DR   PhosphoSitePlus; Q92619; -.
DR   SwissPalm; Q92619; -.
DR   BioMuta; ARHGAP45; -.
DR   DMDM; 187471158; -.
DR   EPD; Q92619; -.
DR   jPOST; Q92619; -.
DR   MassIVE; Q92619; -.
DR   MaxQB; Q92619; -.
DR   PaxDb; Q92619; -.
DR   PeptideAtlas; Q92619; -.
DR   ProteomicsDB; 27852; -.
DR   ProteomicsDB; 75372; -. [Q92619-1]
DR   Antibodypedia; 10356; 209 antibodies from 29 providers.
DR   DNASU; 23526; -.
DR   Ensembl; ENST00000313093.7; ENSP00000316772.2; ENSG00000180448.11. [Q92619-1]
DR   Ensembl; ENST00000539243.6; ENSP00000439601.1; ENSG00000180448.11. [Q92619-2]
DR   GeneID; 23526; -.
DR   KEGG; hsa:23526; -.
DR   MANE-Select; ENST00000313093.7; ENSP00000316772.2; NM_012292.5; NP_036424.2.
DR   UCSC; uc002lqz.4; human. [Q92619-1]
DR   AGR; HGNC:17102; -.
DR   CTD; 23526; -.
DR   DisGeNET; 23526; -.
DR   GeneCards; ARHGAP45; -.
DR   HGNC; HGNC:17102; ARHGAP45.
DR   HPA; ENSG00000180448; Group enriched (bone marrow, intestine, lung, lymphoid tissue).
DR   MIM; 601155; gene.
DR   neXtProt; NX_Q92619; -.
DR   NIAGADS; ENSG00000180448; -.
DR   OpenTargets; ENSG00000180448; -.
DR   PharmGKB; PA128394633; -.
DR   VEuPathDB; HostDB:ENSG00000180448; -.
DR   eggNOG; KOG1453; Eukaryota.
DR   GeneTree; ENSGT00950000183110; -.
DR   HOGENOM; CLU_006236_0_1_1; -.
DR   InParanoid; Q92619; -.
DR   OMA; PLACLCR; -.
DR   OrthoDB; 5395569at2759; -.
DR   PhylomeDB; Q92619; -.
DR   TreeFam; TF351450; -.
DR   PathwayCommons; Q92619; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-8980692; RHOA GTPase cycle.
DR   Reactome; R-HSA-9013148; CDC42 GTPase cycle.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   SignaLink; Q92619; -.
DR   BioGRID-ORCS; 23526; 44 hits in 1160 CRISPR screens.
DR   ChiTaRS; ARHGAP45; human.
DR   EvolutionaryTrace; Q92619; -.
DR   GeneWiki; HMHA1; -.
DR   GenomeRNAi; 23526; -.
DR   Pharos; Q92619; Tbio.
DR   PRO; PR:Q92619; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q92619; protein.
DR   Bgee; ENSG00000180448; Expressed in granulocyte and 156 other tissues.
DR   ExpressionAtlas; Q92619; baseline and differential.
DR   Genevisible; Q92619; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0032587; C:ruffle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0005096; F:GTPase activator activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0090630; P:activation of GTPase activity; IBA:GO_Central.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd20816; C1_GMIP-like; 1.
DR   Gene3D; 1.20.1270.60; Arfaptin homology (AH) domain/BAR domain; 1.
DR   Gene3D; 1.10.555.10; Rho GTPase activation protein; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR031160; F_BAR.
DR   InterPro; IPR001060; FCH_dom.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   PANTHER; PTHR15228:SF18; RHO GTPASE-ACTIVATING PROTEIN 45; 1.
DR   PANTHER; PTHR15228; SPERMATHECAL PHYSIOLOGY VARIANT; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SUPFAM; SSF103657; BAR/IMD domain-like; 1.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 1.
DR   SUPFAM; SSF48350; GTPase activation domain, GAP; 1.
DR   PROSITE; PS51741; F_BAR; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Cell projection;
KW   Coiled coil; Cytoplasm; Direct protein sequencing; GTPase activation;
KW   Membrane; Metal-binding; Phosphoprotein; Reference proteome; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..1136
FT                   /note="Rho GTPase-activating protein 45"
FT                   /id="PRO_0000330312"
FT   PEPTIDE         137..145
FT                   /note="Minor histocompatibility antigen HA-1"
FT                   /id="PRO_0000330313"
FT   DOMAIN          269..539
FT                   /note="F-BAR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01077"
FT   DOMAIN          761..974
FT                   /note="Rho-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00172"
FT   ZN_FING         702..747
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          1..73
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          91..110
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          583..662
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1061..1136
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          376..412
FT                   /evidence="ECO:0000255"
FT   COILED          440..499
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1061..1076
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1095..1111
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         23
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         25
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243"
FT   MOD_RES         73
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         93
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         99
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19367720,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         569
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19367720,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         578
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         592
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         619
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         949
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1027
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TBD2"
FT   MOD_RES         1030
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TBD2"
FT   MOD_RES         1032
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TBD2"
FT   VAR_SEQ         1..30
FT                   /note="MFSRKKRELMKTPSISKKNRAGSPSPQPSG -> MSRGQRVLKGLLGWVCTW
FT                   TWAWRARLGARGCGLHVLCPRDLPLPPE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044707"
FT   VARIANT         139
FT                   /note="R -> H (in allele HA-1H; induction of CTL
FT                   recognition for epitope HA-1; dbSNP:rs1801284)"
FT                   /evidence="ECO:0000269|PubMed:10958358,
FT                   ECO:0000269|PubMed:16202172, ECO:0000269|PubMed:16399573,
FT                   ECO:0000269|PubMed:9461441, ECO:0000269|PubMed:9820595,
FT                   ECO:0000269|Ref.5"
FT                   /id="VAR_042693"
FT   VARIANT         259
FT                   /note="E -> D (in dbSNP:rs2074442)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_042694"
FT   VARIANT         439
FT                   /note="S -> G (in dbSNP:rs7251797)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_042695"
FT   VARIANT         515
FT                   /note="M -> I (in dbSNP:rs36084354)"
FT                   /id="VAR_042696"
FT   VARIANT         886
FT                   /note="A -> P (in dbSNP:rs34569196)"
FT                   /id="VAR_042697"
FT   CONFLICT        648
FT                   /note="S -> F (in Ref. 3; BAG62086)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1136 AA;  124614 MW;  9536787B3B1EE16D CRC64;
     MFSRKKRELM KTPSISKKNR AGSPSPQPSG ELPRKDGADA VFPGPSLEPP AGSSGVKATG
     TLKRPTSLSR HASAAGFPLS GAASWTLGRS HRSPLTAASP GELPTEGAGP DVVEDISHLL
     ADVARFAEGL EKLKECVLRD DLLEARRPRA HECLGEALRV MHQIISKYPL LNTVETLTAA
     GTLIAKVKAF HYESNNDLEK QEFEKALETI AVAFSSTVSE FLMGEVDSST LLAVPPGDSS
     QSMESLYGPG SEGTPPSLED CDAGCLPAEE VDVLLQRCEG GVDAALLYAK NMAKYMKDLI
     SYLEKRTTLE MEFAKGLQKI AHNCRQSVMQ EPHMPLLSIY SLALEQDLEF GHSMVQAVGT
     LQTQTFMQPL TLRRLEHEKR RKEIKEAWHR AQRKLQEAES NLRKAKQGYV QRCEDHDKAR
     FLVAKAEEEQ AGSAPGAGST ATKTLDKRRR LEEEAKNKAE EAMATYRTCV ADAKTQKQEL
     EDTKVTALRQ IQEVIRQSDQ TIKSATISYY QMMHMQTAPL PVHFQMLCES SKLYDPGQQY
     ASHVRQLQRD QEPDVHYDFE PHVSANAWSP VMRARKSSFN VSDVARPEAA GSPPEEGGCT
     EGTPAKDHRA GRGHQVHKSW PLSISDSDSG LDPGPGAGDF KKFERTSSSG TMSSTEELVD
     PDGGAGASAF EQADLNGMTP ELPVAVPSGP FRHEGLSKAA RTHRLRKLRT PAKCRECNSY
     VYFQGAECEE CCLACHKKCL ETLAIQCGHK KLQGRLQLFG QDFSHAARSA PDGVPFIVKK
     CVCEIERRAL RTKGIYRVNG VKTRVEKLCQ AFENGKELVE LSQASPHDIS NVLKLYLRQL
     PEPLISFRLY HELVGLAKDS LKAEAEAKAA SRGRQDGSES EAVAVALAGR LRELLRDLPP
     ENRASLQYLL RHLRRIVEVE QDNKMTPGNL GIVFGPTLLR PRPTEATVSL SSLVDYPHQA
     RVIETLIVHY GLVFEEEPEE TPGGQDESSN QRAEVVVQVP YLEAGEAVVY PLQEAAADGC
     RESRVVSNDS DSDLEEASEL LSSSEASALG HLSFLEQQQS EASLEVASGS HSGSEEQLEA
     TAREDGDGDE DGPAQQLSGF NTNQSNNVLQ APLPPMRLRG GRMTLGSCRE RQPEFV
//
